Erratum: HMOX1 and GST variants modify attenuation of FEF25-75% decline due to PM10 reduction (European Respiratory Journal (2010) 35, (505-514) DOI: 10.1183/09031936.000443-2009);HMOX1 and GST variants modify attenuation of FEF25-75% decline due to PM10 reduction

European Respiratory Journal

Volumn 35, Issue 3, 2010, Pages 505-514

  Curjuric, I ^a,e,o   Imboden, M ^a,ah   Schindler, C ^e,p   Downs, S H ^e   Hersberger, M ^b   Liu, S L J ^e,g   Matyas, G ^c   Russie, E W ^d   Schwartz, J ^h,ae   Thun, G A ^a,ah   Postma, D S ⁱ   Rochat, T ^f,j   Probst Hensch, N M ^a,o   Ackermann Liebrich, U ^k   Gaspoz, J M ^l   Leuenberger, P ^m   Liu, L J S ⁿ   Barthelemy J C ^q   Berger, W ^r   Bettschart, R ^s   Bircher, A ^t   Bolognini, G ^u   Brondli, O ^v   Brutsche, M ^w   Burdet, L ^x   Frey, M ^s   Gerbase, M W ^j   Gold, D ^y   Karrer, W ^z   Keller, R ^s   Knopfli B ^aa   Kunzli N ⁿ   Neu, U ^ab   Nicod, L P ^m   Pons, M ^u   Russi, E W ^ac   Schmid Grendelmeyer, P ^ad   Straehl, P ^ab   Tschopp, J M ⁿ   Von Eckardstein, A ^af   Zellweger, J P ^m   Zemp Stutz, E ^k   Bridevaux, P O ^j   Dratva, J ^k   Felber Dietrich, D ^ag   Gemperli, A ^p   Keidel, D ^p   Phuleria, H ⁿ   more..

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g UNIVERSITY OF WASHINGTON   (United States)

^h HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^j Pneumology   (Switzerland)

^k Hospital Epidemiology   (Switzerland)

^l Cardiology Service   (Switzerland)

^m Pneumology   (Switzerland)

ⁿ Epidemiology and Exposure   (Switzerland)

^o Epidemiology   (Switzerland)

^p Statistical Consulting   (Switzerland)

^q Cardiology   (France)

^r Genetic and Molecular Biology   (Switzerland)

^s Pneumology Clinic   (Switzerland)

^t Department of Dermatology   (Switzerland)

^u Pneumology   (Switzerland)

^v Pneumology   (Switzerland)

^w Pneumology   (Switzerland)

^x Pneumology   (Switzerland)

^y Epidemiology and Cardiology   (Switzerland)

^z Pneumology   (Switzerland)

^aa Division of Pneumology   (Switzerland)

^ab Exposure   (Switzerland)

^ac Pneumology   (Switzerland)

^ad Allergology   (Switzerland)

^ae Health Effects Institute   (United States)

^af UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^ag Kantonsspital   (Switzerland)

^ah Genetic and Molecular Biology   (Canada)

more..

Author keywords

Exposure to particles with a 50 cut off aerodynamic diameter of 10 m; Forced expiratory flow at 25 75 of forced vital capacity; General population sample; Glutathione s transferase; Haem oxygenase 1; Lung function decline

Indexed keywords

GLUTATHIONE TRANSFERASE; HEME OXYGENASE 1;

ADULT; ARTICLE; DNA POLYMORPHISM; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; GENETIC VARIABILITY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PARTICULATE MATTER; PRIORITY JOURNAL; SPIROMETRY;

EID: 77951157276     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.500443-2009     Document Type: Erratum

References (32)

1. Ackermann-Liebrich U, Leuenberger P, Schwartz J, et al. Lung function and long term exposure to air pollutants in Switzerland. Study on Air Pollution and Lung Diseases in Adults (SAPALDIA) Team. Am J Respir Crit Care Med 1997; 155: 122-129.
2. Downs SH, Schindler C, Liu LJ, et al. Reduced exposure to PM10 and attenuated age-related decline in lung function. N Engl J Med 2007; 357: 2338-2347.
3. Abbey DE, Burchette RJ, Knutsen SF, et al. Long-term particulate and other air pollutants and lung function in nonsmokers. Am J Respir Crit Care Med 1998; 158: 289-298.
4. MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 2001; 429: 195-207.
5. Cascio WE. Cardiopulmonary health effects of air pollution: is a mechanism emerging? Am J Respir Crit Care Med 2005; 172: 1482-1484.
6. Fredenburgh LE, Perrella MA, Mitsialis SA. The role of heme oxygenase-1 in pulmonary disease. Am J Respir Cell Mol Biol 2007; 36: 158-165.
7. Guénégou A, Leynaert B, Bénessiano J, et al. Association of lung function decline with the heme oxygenase-1 gene promoter microsatellite polymorphism in a general population sample. Results from the European Community Respiratory Health Survey (ECRHS), France. J Med Genetics 2006; 43: e43.
8. Siedlinski M, van Diemen CC, Postma DS, et al. Heme oxygenase 1 variations and lung function decline in smokers: proof of replication. J Med Genetics 2008; 45: 400.
9. Ugenskiene R, Sanak M, Sakalauskas R, et al. Genetic polymorphisms in chronic obstructive pulmonary disease. Medicina (Kaunas, Lithuania) 2005; 41: 17-22.
10. Rahman I. Regulation of glutathione in inflammation and chronic lung diseases. Mutat Res 2005; 579: 58-80.
11. Sundberg K, Johansson AS, Stenberg G, et al. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 1998; 19: 433-436. (Pubitemid 28375445)
12. Imboden M, Downs SH, Senn O, et al. Glutathione S-transferase genotypes modify lung function decline in the general population: SAPALDIA cohort study. Respir Res 2007; 8: 2.
13. Gilliland FD, Gauderman WJ, Vora H, et al. Effects of glutathione-S-transferase M1, T1, and P1 on childhood lung function growth. Am J Respir Crit Care Med 2002; 166: 710-716.
14. Ackermann-Liebrich U, Kuna-Dibbert B, Probst-Hensch NM, et al. Follow-up of the Swiss Cohort Study on Air Pollution and Lung Diseases in Adults (SAPALDIA 2) 1991-2003: methods and characterisation of participants. Soz Praventivmed 2005; 50: 245-263.
15. Burney PG, Luczynska C, Chinn S, et al. The European Community Respiratory Health Survey. Eur Respir J 1994; 7: 954-960.
16. Standardisation of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152: 1107-1136.
17. Martin BW, Ackermann-Liebrich U, Leuenberger P, et al. SAPALDIA: methods and participation in the cross-sectional part of the Swiss Study on Air Pollution and Lung Diseases in Adults. Soz Praventivmed 1997; 42: 67-84.
18. Dreborg S. Skin tests used in type I allergy testing. Position paper of the European Academy of Allergology and Clinical Immunology. Allergy 1989; 44: Suppl. 10, 52-59.
19. Stephens M, Smith N, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989.
20. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162-1169.
21. Liu LJS, Curjuric I, Keidel D, et al. Characterization of source-specific air pollution exposure for a large population-based Swiss cohort (SAPALDIA). Environ Health Perspect 2007; 115: 1638-1645.
22. SAEFL. Modelling of PM10 and PM2.5 ambient concentrations in Switzerland 2000 and 2010. Environmental Documentation No 169 Air. Berne, Swiss Agency for the Environment, Forests, and Landscape, 2003.
23. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
24. Kampa M, Castanas E. Human health effects of air pollution. Environ Pollut 2008; 151: 362-367.
25. Lee YL, Lin YC, Lee YC, et al. Glutathione S-transferase P1 gene polymorphism and air pollution as interactive risk factors for childhood asthma. Clin Exp Allergy 2004; 34: 1707-1713.
26. Islam T, Berhane K, McConnell R, et al. Glutathione-S-Transferase (GST) P1, GSTM1, exercise, ozone and asthma incidence in school children. Thorax 2008; 64: 197-202.
27. Romieu I, Ramirez-Aguilar M, Sienra-Monge JJ, et al. GSTM1 and GSTP1 and respiratory health in asthmatic children exposed to ozone. Eur Respir J 2006; 28: 953-959.
28. Melen E, Nyberg F, Lindgren CM, et al. Interactions between glutathione S-transferase P1, tumor necrosis factor, and traffic-related air pollution for development of childhood allergic disease. Environ Health Perspect 2008; 116: 1077-1084.
29. Gilliland FD, Li Y-F, Saxon A, et al. Effect of glutathione-Stransferase M1 and P1 genotypes on xenobiotic enhancement of allergic responses: randomised, placebo-controlled crossover study. Lancet 2004; 363: 119-125.
30. Pritchard JK, Rosenberg NA. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 1999; 65: 220-228.
31. Roewer L, Croucher PJP, Willuweit S, et al. Signature of recent historical events in the European Y-chromosomal STR haplotype distribution. Hum Genet 2005; 116: 279-291.
32. Kramer CB, Cullen AC, Faustman EM. Policy implications of genetic information on regulation under the Clean Air Act: the case of particulate matter and asthmatics. Environ Health Perspec 2006; 114: 313-319.